March 25th 2025
Pharmacists can promote prevention through the implementation of antimicrobial stewardship initiatives and advocate for fecal microbiota transplant.
FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection
December 1st 2022Live-jslm (Rebyota; Ferring Pharmaceuticals) is indicated for the prevention of recurring Clostridioides difficile infection among patients 18 years of age and older after an antibiotic treatment.
Read More
Risankizumab Demonstrates Significant Improvements In Patients with Crohn Disease
January 11th 2021A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.
Read More
Plethora of Clinical Trials Explore Gastric Cancer Treatments
Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.
Read More
Survey Shows Adopting New Vancomycin Guidelines is Priority for Pharmacists Despite Pandemic
April 16th 2020A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.
Read More